GCIA
RVNC

Gabelli & Co Investment Advisers’s Revance Therapeutics, Inc. RVNC Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,058,500
Closed -$3.22M – 285
2024
Q4 		$3.22M Buy
1,058,500
+218,700
+26% +$665K 0.55% 46
2024
Q3 		$4.36M Buy
+839,800
New +$4.36M 0.74% 41